Skip to main content

InvestorNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Set to Benefit from Enactment of FDA-Proposed OTC Hearing Aids Law

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently launched its world-class hearing aids and related products on multiple websites. InnerScope has partnered with the online retailer and industry leader in the U.S. tax-free health care market. Furthermore, its hearing aids and other portfolio products qualify as eligible for flexible spending accounts (“FSA”) and health saving account users, and InnerScope is the only company on the retailers’ websites to offer hearing aids. InnerScope has also acquired iHEAR Medical Inc. and struck another major deal, inking a letter of intent to acquire Hearing Assist II LLC. This comes as the FDA is spearheading a charge towards affordability and accessibility for up to 70 million Americans suffering from impaired hearing. “In a landmark proposal, the FDA wants to see a new category of over-the-counter (‘OTC’) hearing aids catering to people with mild to moderate hearing loss that generally go without any hearing assistance,” explains a recent article. “These regulatory changes, which still must undergo a 90-day comment period before a 60-day implementation deadline, are beneficial to direct-to-consumer specialists like InnerScope, which manufactures, develops, distributes and sells innovative hearing health-products, solutions and treatments.”

To view the full article, visit https://ibn.fm/KXQFe

About InnerScope Hearing Technologies Inc.

InnerScope is a leading manufacturer and distributor of FDA-registered hearing products and personal sound amplifier products (“PSAPs”), dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s products and business model break through the persistent barriers that prevent access to effective hearing solutions. With its recent acquisition of iHEAR Medical, InnerScope is poised to expand its leadership in the direct-to-consumer hearing solutions market with innovative hearing products offered to consumers at a fraction of the cost of conventional hearing aids sold in hearing aid centers. For more information about the company, visit www.INND.com.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.